RBC Capital Downgrades PDL BioPharma (PDLI) to Sector Perform, Maintains Price Target
Go back to RBC Capital Downgrades PDL BioPharma (PDLI) to Sector Perform, Maintains Price Target| PDL BioPharma, Inc. (NASDAQ: PDLI) | Delayed: 2.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.47 | 52 Week High | $4.06 | |||
| Open | $0.14 | 52 Week Low | $2.58 | |||
| Day High | $2.47 | P/E | 1.44 | |||
| Day Low | $2.47 | EPS | $1.71 | |||
| Volume | 1,000 | |||||
